Nutex Health Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Nutex Health Inc.
- Former names
- Clinigence Holdings, Inc. iGambit, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 7389 — Services-Business Services, NEC
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Houston
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NUTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001479681
- EIN
- 11-3363609
Board of directors
-
Cheryl Yvonne Grenas · DirectorSince 2023
-
Danniel Stites · DirectorSince 2023
-
Frank E. Jaumot · DirectorSince 2025
-
John J. Waters · DirectorSince 2023
-
Kelvin Spears · DirectorSince 2024
-
Michael Lee Reed · DirectorSince 2023
-
Mitchell Creem · DirectorSince 2023
-
Scott J. Saunders · DirectorSince 2024
-
Thomas T. Vo · Director · Chief Executive OfficerSince 2023
-
Warren Hosseinion · Director · PresidentSince 2023
Chief executives
Thomas T. Vo
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of April 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.1%
-
95.5%
-
95.8%
-
96.6%
-
96.7%
-
96.7%
-
99.3%
Board connections
2 of this board's directors also sit on 4 other boards.
- via Warren Hosseinion
- via Warren Hosseinion
- via Mitchell Creem
- via Warren Hosseinion
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $148,237
- 5 purchases by 5 insiders
- Sold, last 12 months
- $43,493
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Scott J. Saunders Director | Open-market sale | −203 | $214.25 | $43,493 |
| Jul 31, 2026 | Cheryl Yvonne Grenas Director | Option exercise | +603 | — | — |
| Jul 31, 2026 | Frank E. Jaumot Director | Option exercise | +603 | — | — |
| Jul 31, 2026 | Michael Lee Reed Director | Option exercise | +603 | — | — |
| Jul 31, 2026 | Scott J. Saunders Director | Option exercise | +603 | — | — |
| Jun 4, 2026 | Kelvin Spears Director | Other | +2,519 | — | — |
| May 28, 2026 | Thomas T. Vo Director, Officer (Chief Executive Officer) | Other | +75,747 | — | — |
| Apr 9, 2026 | Thomas T. Vo Director, Officer (Chief Executive Officer) | Other | +184,071 | — | — |
| Mar 20, 2026 | Frank E. Jaumot Director | Open-market purchase | +150 | $93.56 | $14,034 |
| Mar 19, 2026 | Warren Hosseinion Director, Officer (President) | Open-market purchase | +252 | $94.07 | $23,706 |
| Mar 17, 2026 | Kelvin Spears Director | Open-market purchase | +10 | $94.46 | $945 |
| Mar 13, 2026 | Montgomery Pamela W. Officer (Chief Legal Officer-Healthcare) | Open-market purchase | +79 | $88.87 | $7,021 |
| Mar 10, 2026 | Luqman Elisa V Officer (Chief Legal Officer - SEC) | Option exercise | +2,084 | — | — |
| Mar 10, 2026 | Montgomery Pamela W. Officer (Chief Legal Officer-Healthcare) | Option exercise | +2,084 | — | — |
| Mar 10, 2026 | Kelvin Spears Director | Option exercise | +183 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.